Telix Pharmaceuticals | TLX - Net Income

Stock Price
10.08
Daily Change
-0.13 -1.23%
Monthly
-13.52%
Yearly
-64.60%
Q1 Forecast
10.21

Telix Pharmaceuticals reported AUD-4.83M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Cochlear AUD 91.9M 113.2M Jun/2025
CSL USD 497.5M 1.51B Jun/2025
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Mayne Pharma AUD -103.68M 68.4M Jun/2024
Medical Developments International AUD -105K 409K Jun/2025
Mesoblast USD -54.21M 6.27M Jun/2025
Neuren Pharmaceuticals AUD 7.52M 126.51M Jun/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
Paradigm Biopharmaceuticals AUD -6.42M 495.95K Jun/2025
Polynovo AUD 1.28M 1.41M Jun/2024
PYC Therapeutics AUD -12.37M 13.2M Jun/2025
Ramsay Health Care AUD 120.3M 225.2M Jun/2025
ResMed USD 392.59M 44.05M Dec/2025
Sonic Healthcare AUD 236.68M 82.29M Dec/2024